header

Poster sessions on Friday, March 23

Poster session 1 (P01–P10), 9:00–10:00: Ig-apheresis and Miscellaneous

Chairs: A. Kronbichler (Innsbruck, Austria), B. Hohenstein (Villingen-Schwenningen, Germany)

09:00-09:05
P-01
*Z. Tsonchev, M. Bozhilova, M. Daskalov, P. Kenarov, A. Momchilova, A. Alexandrov (Sofia, Bulgaria)
Experience for treatment thrombotic thrombocytopenic purpura disease with plasmapheresis using nanotechnology membrane

09:05-09:10
P-02
*M. Lánská, M. Bláha, I. Krčmova, P. Žák (Hradec Kralove, Czech Republic)
Extracorporeal IgE Immunoadsorption in Alleric Asthma – first centre experience

09:10-09:15
P-03
O. Dmitrieva, O. Afanasieva, P. Levashov, *S. Pokrovsky (Moscow, Russian Federation)
Comparative in vitro analysis of three systems for endotoxin removal (LPS adsorption)

09:15-09:20
P-04
*I. Adamova, M. Afanasieva, E. Utkina, Y. Beresttskaya, N. Pokrovsky, O. Afanasieva, S. Pokrovsky (Moscow, Russian Federation)
Sorbents for selective removal of sFlt-1 to treat preeclampsia

09:20-09:25
P-05
*O. Afanasieva, M. Afanasieva, I. Adamova, E. Vichrova, N. Pokrovsky, P. Levashov, S. Pokrovsky (Moscow, Russian Federation)
Antibodies and synthetic ligands containing sorbents for Ig apheresis (in vitro comparison study)

09:25-09:30
P-06
*M. Scully (London, UK), S. Cataland (Columbus, United States), F. Peyvandi (Milano, Italy), P. Coppo (Paris, France), P. Knöbl (Vienna, Austria), J. Kremer Hovinga (Bern, Switzerland), A. Metjian (Durham, United States), J. de la Rubia (Valencia, Spain), K. Pavenski (Toronto, Canada), F. Callewaert, D. Biswas, H. De Winter, R.K. Zeldin  (Ghent, Belgium)
Caplacizumab for acquired thrombotic thrombocytopenic purpura – results of the phase 3 HERCULES study

09:30-09:35
P-07
*C. Schmidt- Rimpler, S. Uthoff, D. Kramer, M. Fischer (Bad Homburg, Germany)
Immunoadsorption in Dilated Cardiomyopathy – what the literature tells us

09:35-09:40
P-08
*S. Bardakov, A. Sokolov, D. Skulyabin, M. Zacharov, S. Lapin, A. Mazing (St. Petersburg, Russian Federation)
Effects of therapeutic apheresis methods in treatment of STIFF-person syndrom

09:40-09:45
P-09
*F. Kälble, L. Pego da Silva, M. Schaier, M. Zeier, A. Mehrabi, C. Süsal, C. Morath (Heidelberg, Germany)
Outcomes following living donor kidney transplantation in patients with donor-specific HLA antibodies after desensitization with immunoadsorption

09:45-09:50
P-10
*C. A. Rae, J. Barnes, J. A. Diaz Aunon, J. Simoni (Rapid City, United States)
A novel smart adsorbent for extracorporeal blood purification therapy


 

Poster session 2 (P11–P22), 10:30–11:30 Lp-apheresis

Chairs: B. Jaeger (Mühlheim a.d.Ruhr, Germany) , A. Vogt (Munich, Germany)

10:30-10:35
P-11
*J. Otto, D. Handschel, G. Maniera (Cologne, Germany)
Removal of Xanthomas and Xanthelasmas by LDL-Apheresis in a Case of severe Familial Hypercholesterolemia (FH)

10:35-10:40
P-12
*M. Chocholous, A. Handisurya (Vienna, Austria)
Direct Adsorption of Lipoproteins (DALI®) Apheresis for Elevated Lipoprotein(a) During Pregnancy – A Case Report

10:40-10:45
P-13
*O. Afanasieva, O. Razova, M. Ezhov, A. Popova, E. Utkina, M. Afanasieva, S. Pokrovsky (Moscow, Russian Federation)
Lipoprotein(a), PCSK9 and complex Lp(a)-PCSK9 plasma levels in hypercholesterolemia patients

10:45-10:50
P-14
*N. K. Walleczek, K. Arbeiter, P. R. Espina, T. Hörtenhuber, A. Kreissl, S. Greber-Platzer (Vienna, Austria)
Effects of a newly established lipid apheresis for a young homozygous familial hypercholesterolemia population at the Department of Pediatrics and Adolescent Medicine in Vienna

10:50-10:55
P-15
*A. Giurgea, E. Karkutli, H. Sinzinger (Vienna, Austria)
Left ventricular ejection fraction after 1 year Lipoprotein apheresis

10:55-11:00
P-16
*A. Klink, A. Hilge, S. Volkholz, K. Maier, H. Jütte, S. Rummler (Jena, Germany)
Lipoprotein-Apheresis with the Spectra Optia Apheresis System

11:00-11:05
P-17
V. E. Varga, H. Lőrincz, A. Szentpéteri, L. Juhász, I. Seres, J. Balla, G. Paragh, *M. Harangi (Debrecen, Hungary)
Changes in some pro- and antioxidant parameters after selective LDL apheresis

11:05-11:10
P-18
*T. Berent (Vienna, Austria), M. Halilovic (Vienna, Austria), R. Berent (Bad Ischl, Austria), H. Sinzinger (Vienna, Austria)
Intensified treatment regimen of regular lipoprotein apheresis in patients with elevated lipoprotein(a) and clinically progressive atherosclerotic disease: two case reports

11:10-11:15
P-19
*E. Ovchinnikova, I. Adamova, E. Utkina, P. Levashov, S. Pokrovsky (Moscow, Russian Federation)
Affinity sorbents based on tryptamine and tyramine for practical use in medicine and biotechnology

11:15-11:20
P-20
*D. Dlouha, J. Pitha, Z. Eretova, J. Hubacek, A. Parikova, O. Viklicky (Prague, Czech Republic)
Effect of LDL/Lp(a) apheresis treatment on plasma levels of miRNAs in patients with high Lp(a), a follow-up study

11:20-11:25
P-21
*J. Piel, K. Lilienthal (Tallinn, Estonia)
Lipoprotein Apheresis Administration Experience in Estonia: Case Report

11:25-11:30
P-22
*U. Schatz, S. Fischer, S. Tselmin, G. Müller, U. Julius, S. R. Bornstein (Dresden, Germany)
Risk factor constellation in patients with premature cardiovascular events

 

 

Poster session 3 (P25–P32), 13:45–14:45: Miscellaneous 2

Chairs: U. Julius (Dresden, Germany), H. Sinzinger (Vienna, Austria)

 

P-23
This poster has been withdrawn.

P-24
This poster has been withdrawn.

13:45-13:52
P-25
*Á. Diószegi, M. Nánásy-Vass, N. Németh, M. Káplár, K. Veres, P. Soltész (Debrecen, Hungary)
Rheopheresis in diabetic foot ulceration– Results of 3 years follow-up

13:52-14:00
P-26
*B. Stegmayr and the WAA Registry Study Group (Umea, Sweden et al.)
Data from the WAA register – Up date of patients 21 years and older

14:00-14:08
P-27
*K. Artinger, T. Niedrist, A. Meinitzer, A. R. Rosenkranz, K. Eller (Graz, Austria)
Iron deficiency in patients undergoing immunoadsorption

14:08-14:16
P-28
*M. Blaha, H. Langrova, V. Blaha, M. Lanska, J. Studnicka, A. Stepanov (Hradec Králové, Czech Republic)
Dynamics of proprotein convertase subtilisin kexin 9 (PCSK9) in the treatment with rheopheresis in age related macular degeneration

14:16:14:23
P-29
*D. Dlouha (Prague), I. Prochazkova (Prague), M. Blaha (Hradec Králové), V. Blaha (Hradec Králové), I. Fatorova (Hradec Králové), J. Hubacek (Prague), J. Pitha (Prague)
Amount of RNA contamination in samples from the rinse of the apheresis column

14:23-14:30
P-30
*T. Berent (Vienna, Austria), S. Steiner (Leipzig, Germany), R. Berent (Bad Ischl, Austria), H. Sinzinger (Vienna, Austria)
Anatomical mapping of muscle-related side-effects of statins

14:30-14:37
P-31
*M. Nagel, M. Benke, I. Duma, C. Vlad, T. Lucke, S. Nagorka (Weißwasser, Germany)
Molecular genetic diagnosis helps to predict the outcome of PCSK9 inhibitor therapy

14:37-14:45
P-32
*S. Perrone, R. Brunelli, G. Perrone, P. Galoppi, I. Zannini, S. Di Giacomo, C. Morozzi, C. Stefanutti (Rome, Italy)
A successful term pregnancy with severe hypertriglyceridemia and acute pancreatitis: case report and literature review


Explanation:
*T. Berent = Main author
R. Berent = Presenting author

Search

Newsletter

Yes, keep me updated for this event

@

Important Dates

February 15, 2018
Deadline for abstract submission and early bird registration

March 14, 2018
Deadline for standard registration (on-site registration still possible)

March 22 – 24, 2018
2nd Congress of the European Group - International Society for Apheresis (E-ISFA)

Travel Arrangement



Please click here for more information about special rates offered by Lufthansa Group.

Scientific coordination

Scientific chairs

Prof. Dr. Kurt Derfler
Vienna General Hospital - University Campus of Medicine
Währinger Gürtel 18–20
1090 Vienna, Austria

Prof. Dr. Helmut Sinzinger
ATHOS Institute
Nadlergasse 1
1090 Vienna, Austria

Scientific coordination (nurses):

Elodie Karkutli, BSc.
ATHOS Institute
Nadlergasse 1
1090 Vienna, Austria

STPL Michaela Frisch-Peterka
Vienna General Hospital – University Campus of Medicine
Währinger Gürtel 18–20
1090 Vienna, Austria
Organizer
Austrian Apheresis Association
Nadlergasse 1/2
1090 Vienna, Austria

  +43  1 4082633
  info@austrian-apheresis-association.at

Congress secretariat

K.I.T. Group GmbH Dresden
K.I.T. Group GmbH Dresden
Bautzner Str. 117–119
01099 Dresden

  +49 351 4842731
  info@e-isfa2018.eu